Posted on December 4th, 2013
Umbilical/abdominal hernias are hernias that occur within the belly button area and can be caused by obesity or anything that aggravates pressure in the abdomen, such as a consistent cough or severe constipation.
There is no known treatment for umbilical/abdominal hernias except surgically, which is either done with a short incision (causing the patient to spend at least 24 to 48 hours in the hospital) or via laparoscopy, which makes use of a thin, lighted tube that is put through an incision into the abdominal wall and is a minimally-invasive operation.
Non-treatment of this type of hernia is dangerous as it can cause “strangulation,” which causes the contents of the hernia sac to become gangrenous within a matter of hours as the blood supply is cut off. Strangulation can happen at any point when you have this type of hernia, even if the hernia has been present in your body for years.
When it comes to treating other types of hernias, the Alloderm hernia patch is often used. Unfortunately, this patch has been shown to cause serious health problems for certain people. If this is the case for you, talk with a lawyer from Williams Kherkher about taking legal action against the manufacturer by calling 800-220-9341.
Posted on December 1st, 2013
A report published in The Herald Bulletin on November 19 states that the number of drug dependent babies born in Indiana has recently been surprisingly high.
Neonatal abstinence syndrome (NAS) is a condition in which babies demonstrate withdrawal signs and symptoms while being weaned off from addictive drugs their mothers took during pregnancy. Illicit or prescription drugs taken by expecting mothers may pass through the placenta and reach the baby during pregnancy, causing him/her to be ‘addicted’.
The Prescription Drug Abuse Task Force, a group of medical and legal experts from Indiana, is concerned the number of babies with NAS in Indiana is reaching an epidemic level.
The task force aims to push a legislative measure that would ensure a more intensive monitoring of pregnant women who are using drugs that can cause NAS. The task force also hopes to create a law that will provide protection to mothers who voluntarily seek medical treatment for their addictions.
Unfortunately, there is a strong link between Zoloft and NAS. If you believe your baby is suffering from withdrawal or other problems because of Zoloft, our lawyers from Williams Kherkher can help you understand your options for filing a legal claim. Learn more about how we can help by calling 800-220-9341 today.
Posted on November 29th, 2013
A Philadelphia jury ordered Johnson & Johnson’s Janssen Pharmaceuticals to pay $11 million to a claimant whose infant sustained birth defects from the epilepsy drug, Topamax.
According to the judge’s ruling, Haley Powell’s son was born with a cleft lip because doctors improperly warned her of Topamax’s side effects during pregnancy.
Powell’s legal team argued that Janssen deliberately refrained from informing doctors and patients that the epilepsy drug causes birth defects. Because of the birth defects, Powell’s son, Brayden is expected to undergo a series of surgeries before he reaches age 21.
Last October, Janssen was ordered to pay April Czimmer $4.02 million in a lawsuit similar to Powell’s.
Birth defects caused by pharmaceuticals are completely preventable. If prescription medicines have caused birth defects to your child and you live in the Houston area, contact Williams Kherkher at 800-220-9341 to find out how you can benefit from legal action.
Posted on November 27th, 2013
The American Heart Association (AHA) recommends that individuals predisposed to experiencing heart attacks take a daily dose of aspirin.
This recommendation is based on research conducted at the Leiden University Medical Center in the Netherlands. The study, written by Tobias Bonten, suggest that taking aspirin at night reduces blood platelet activity in the morning.
Bonten explained that people are most likely to experience heart attacks in the morning when platelet activity is at its peak, so the reduction of platelet activity could make a profound difference.
Some birth control pills, like Yaz and Yasmin, increase the risk for clotting complications and heart attacks. If you have experienced severe circulatory problems while taking these contraceptives in the Houston area, contact Williams Kherkher at 800-220-9341 to find out how our lawyers can advocate for you.
Posted on November 20th, 2013
United Kingdom’s health watchdog the National Institute for Health and Care Excellence (Nice) issued a ban on metal-on-metal hip replacements in early November after careful investigation and research into the failure rates of such devices, which they placed at 43% after nine years.
Before the introduction of metal-on-metal hip implants in the 2000s, artificial hip joints were prevalent. They originated in the 1970s via the works of Dr. Sir John Charnley at the Wrightington Hospital. His artificial joints were made from stainless steel, polyethylene (originally Teflon) acetabular component, and PMMA acrylic bone cement.
According to the agency’s studies, metal-on-metal hip implants are more prone to corrosion, and pose a higher risk to patients for exposure to chromium, cobalt, and other metallic substances.
The agency advocated to have two common types of metal-on-metal hip replacements removed from the market. Its officials also advised patients who already have such devices to undergo yearly check-ups to determine if their toxicity levels are high.
At Williams Kherkher, our legal team is ready to provide legal advice and representation to patients who have suffered from the adverse effects of a DePuy hip implant. Contact us today at 800-220-9341 to find out more about your legal options and how we can help you.
Posted on November 17th, 2013
BP continues to rack up personal, environmental, and economic injury lawsuits concerning the 2010 Deepwater Horizon oil spill. Settlement costs have now moved past the once-agreed on $7.8 billion to approximately $9 billion.
The damage caused to the Gulf of Mexico has negatively affected both commercial and residential properties. All of the residential claim lawsuits and commercial claim lawsuits were organized into a class action.
A business must fulfill two requirements to be covered by the class action settlement. It must be located within the specific geographic region affected by the oil spill. There must be evidence of economic loss based on expected versus actual profit over more than three consecutive months between May and December 2010.
On October 2 District Judge Carl Barbierto was ordered to draft an injunction that would temporarily cease settlement payments until after the final terms could be agreed upon. The settlement’s final terms are expected to be presented by Barbierto on December 2.
If you encounter difficulty filing an oil spill claim with Deepwater Horizon Claims Center in the Houston area, contact Williams Kherkher at 800-220-9341 to learn of the services that we can provide for you.
Posted on November 15th, 2013
On November 9, scientists introduced a new drug that can help aid the fight against iron deficiency for kidney failure patients. The third phase of Triferic’s trials, which involved 300 patients, showed that when the drug was given to patients at each dialysis session for up to 48 weeks, patients maintained hemoglobin levels in a stable fashion.
The phase 3 trials were conducted by Doctors Steven Fishbane and Azzour Hassan from the North Shore-LIJ Health Systems Division of Nephrology in New York along with Harvard Medical School’s associate professor Dr. Ajay Singh.
Triferic delivers iron to the bone marrow rather than directly to the bloodstream, a process that is physiologically healthier in nature. The process also makes sure that iron is delivered to the body without it accumulating in tissues and organs, which can cause damage.
Unfortunately, the widely used dialysis product GranuFlo has been shown to cause patients serious harm. Call our lawyers from Williams Kherkher at 800-220-9341 today if you’ve been harmed by this product and want to learn about your legal options.
Posted on November 15th, 2013
The report “Dialysis Market Global Forecast to 2018,” which analyzed and made projections of the global dialysis products and services market for the period of 2013 to 2018, has forecast that the market, which is estimated to currently be worth $61.60 billion, will grow by a compounded annual growth rate (CAGR) of 6.2% to $83.21 billion by 2018.
A factor of the growth is the emergence of markets such as China and India. North America (United States and Canada) is the largest dialysis market as of 2013 due to factors such as the abundance of U.S. dialysis patients, high reimbursement rates, and the high adoption rate of new technologies.
Among the major players in the kidney dialysis market are Germany’s Fresenius Medical Care, U.S.’s DaVita Healthcare Partners, Inc., Sweden’s Gambro AB, U.S.’s Baxter International, Inc., Germany’s B. Braun Melsungen AG, Japan’s Nipro Corp., Germany’s Diaverum Deutschland GmbH, U.S.’s Medical Components, Inc., Ireland’s Covidien, and U.S.’s NxStage Medical, Inc.
Patients dealing with kidney failure currently have many different treatments they can seek to maintain their health, one of which is the kidney dialysate GranuFlo, manufactured by the Fresenius Medical Group. Unfortunately, this product has been known to cause serious side effects. Call our attorneys from Williams Kherkher at 800-220-9341 today if you have been harmed by this product and want to file a lawsuit.
Posted on November 13th, 2013
While the settlement has not yet been publicly announced, sources with knowledge of the discussions have indicated that Johnson & Johnson, the manufacturers of the DePuy ASR Hip Implant, will pay in excess of $4 billion to settle the more than 7,500 state and federal lawsuits that have been filed against the company. As a result, the company will pay an average of more than $300,000 for each surgery performed using the implant device.
The DePuy ASR Hip Implant was originally marketed by Johnson & Johnson as a safe, effective hip replacement choice thati cr could potentially last as long as 20 years for patients. However, by 2010, the company was forced to recall tens of thousands of the implants as a result of the extraordinarily high failure rate of the devices, with internal Johnson & Johnson documents indicating that as many as 37% had failed and required replacement within fewer than 5 years. Additionally, the metal-on-metal design of the implants has caused patients to suffer a range of other problems, including discomfort and metal toxicity.
One important element of the settlement, according to sources, is that it does not prohibit patients whose artificial hips may fail in the future from seeking compensation. As a result, many more patients may be eligible to receive compensation for the damages they have suffered than those whose cases are being resolved by the current settlement. The attorneys of Williams Kherkher have been involved in the DePuy litigation process for years, and are fully prepared to help clients whose hip implants may have failed or caused health problems to pursue justice.
Get Help Today
Williams Kherkher is a mass tort law firm based in Houston, Texas that provides national representation to individuals who have been injured by defective medical products, including the DePuy hip implant. If you have been injured as a result of DePuy products, contact the attorneys at Williams Kherkher today by calling 800-220-9341 to learn more about your rights and options under the law.
Posted on November 12th, 2013
On Monday, November 4, London-based BP (formerly known as British Petroleum), Gulf Coast residents, and businesses faced off at the Fifth U.S. Circuit Court of Appeals to hear BP’s objections to the $7.8-billion dollar deal that was supposed to pay residents and businesses for the damages caused by the 2010 Gulf of Mexico oil spill.
BP is anxious about the possibility that it might be paying out inflated or fake claims by fraudulent businesses since claims administrator Patrick Juneau allowed businesses to modify how they calculate the actual amount for lost profits in January.
As of Friday, November 1, BP has already paid an estimated $3.7 billion to around 38,000 people and businesses. It has yet to agree to a specific amount of business payouts as of recent developments.
The Deepwater Horizon oil spill in the Gulf of Mexico has affected many people and businesses, causing serious life changes and losses. At Williams Kherkher, our lawyers make sure that people who have legitimate claims following this oil spill get the compensation they need. Call us at 800-220-9341 today so we can help you process your claim.